Stay updated on Pembrolizumab in MPM Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in MPM Clinical Trial page.

Latest updates to the Pembrolizumab in MPM Clinical Trial page
- CheckyesterdayChange DetectedThe page revision label was updated from v3.6.5 to v3.6.6, indicating a minor release update to the page.SummaryDifference0.0%

- Check8 days agoChange DetectedThe study's official identifiers now include a funding attribution: 2016 ( U.S. NIH Grant/Contract ). This adds NIH funding as part of the study's identifiers.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a small platform update. It does not affect the study details, enrollment, results, or other content presented on the page.SummaryDifference0.0%

- Check36 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing the previous Revision: v3.6.3. This reflects a new deployment/build of the page and does not change the study content.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, signaling a minor update to the study record metadata without altering study content.SummaryDifference0.0%

- Check65 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, signaling a small metadata update to the study record without altering substantive information.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in MPM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in MPM Clinical Trial page.